セッション詳細
International Session（Oral）Award Session2
2025年11月22日(土) 16:45 〜 17:45
第10会場（神戸国際会議場 5F 501）
Chairs: Yuko Shimamoto（Department of Pharmacy, National Cerebral and Cardiovascular Center, Japan）, Masashi Nagata（Department of Pharmacy, Institute of Science Tokyo Hospital, Japan）
[IO2-1]Impact of the medical fee revisions related to polypharmacy in Japan on long-term prescriptions of hypnotic medications in aged patients: An interrupted time series analysis using real-world data
Takeshi Kimura1, Ryunosuke Saeki1, Kazuhiro Yamamoto2, Tomohiro Omura1, Ikuko Yano1 (1.Department of Pharmacy, Kobe University Hospital, Japan, 2.Department of Integrated Clinical and Basic Pharmaceutical Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan)
[IO2-2]Trends of Strong and Weak Opioid Prescriptions in Japan: A Cross-Sectional Study Based on Open Data from the National Database from Fiscal Years 2015 to 2021.
Tomokazu Shoji1,2, Manabu Akazawa2, Nonoka Nakagomi1, Miwako Kobayashi1, Fumihiko Kitta1, Ryo Inose3, Yuichi Muraki3, Tetsuya Iijima4, Takaaki Suzuki1 (1.Department of Pharmacy, University of Yamanashi Hospital, Japan, 2.Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Japan, 3.Laboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Japan, 4.Department of Anesthesiology, Faculty of Medicine, University of Yamanashi, Japan)
[IO2-3]Hospital Size and Antimicrobial Stewardship Impact on Outcomes of Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Nationwide Claims Database Analysis
Keisuke Sawada1,2, Shuji Kono1, Ryo Inose2, Yuichi Muraki2 (1.Department of Pharmacy, Federation of National Public Service Personnel Mutual Aid Associations Hirakata Kohsai Hospital, Japan, 2.Laboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Japan)
[IO2-4]Impact of Pharmacist-Supported TDM Order Entry on Physician Workload and Clinical Outcomes in Emergency Medicine
Sayori Kotera1, Naoki Yoshikawa1,2, Hidehiko Koreeda1, Chiaki Miyata1, Shuichi Nakahara1, Yuki Matsusaki1, Yusei Yamada1, Hiroki Itoh2, Ryuji Ikeda1 (1.Department of Pharmacy, University of Miyazaki Hospital, Japan, 2.Department of Clinical Pharmacy, Oita University Hospital, Japan)
[IO2-5]Evaluation of infliximab biotransformation through comparison of quantification by ligand-binding assay and mass spectrometry
Sho Masui1,2, Aoto Nakajima1, Kodai Yajima1, Takashi Shimada1,3, Akira Onishi2, Shuji Yamamoto2, Masahiro Tsuda2, Tomohiro Terada2, Atsushi Yonezawa1,2 (1.Faculty of Pharmacy, Keio University, Japan, 2.Kyoto University Hospital, Japan, 3.Shimadzu Corporation, Japan)